Detailed price information for Theralase Technologies Inc (TLTFF) from The Globe and Mail including charting and trades.

EBC-129 is an antibody-drug conjugate (ADC) that selectively targets a novel, tumour-specific N-glycosylated epitope found on both CEACAM5 and CEACAM6. The expansion cohort for pancreatic ductal ...

CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung ...

(BUSINESS WIRE )-- CCM Biosciences , a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program ...

TAIPEI, May 16, 2025 /PRNewswire/ -- The broad-spectrum antiviral siRNA drug SNS812, co-developed by Oneness Biotech (4743.TW) and Microbio (Shanghai), has been selected for oral presentation at ...

The broad-spectrum antiviral siRNA drug SNS812, co-developed by Oneness Biotech (4743.TW) and Microbio (Shanghai), has been selected for oral presentation at the prestigious 2025 American Thoracic ...

Microsoft PowerPoint is a program that lets you create presentations and slide decks. PowerPoint is part of Microsoft 365's suite of productivity applications. Learn how to create a new ...

Amid a targeted lobbying effort, Congress weakened the DEA’s ability to go after drug distributors, even as opioid-related deaths continue to rise, a Washington Post and ‘60 Minutes ...

His Expert Algorithm for Substance Identification, or EASI, will allow separate labs using different instruments to meaningfully share data about the chemical profiles of various drugs for the ...